scholarly article | Q13442814 |
P2093 | author name string | Yuri Persidsky | |
Holly Dykstra | |||
Slava Rom | |||
Nancy L Reichenbach | |||
P2860 | cites work | Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. | Q37352700 |
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy | Q37402458 | ||
Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy Antigen Receptor for Chemokines | Q37429317 | ||
The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets | Q37770152 | ||
Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells | Q38324533 | ||
Sera from HIV-1 infected individuals in all stages of disease preferentially recognize the V3 loop of the prototypic macrophage-tropic glycoprotein gp120 ADA. | Q38981659 | ||
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium | Q39077826 | ||
Lipopolysaccharide activates ERK-PARP-1-RelA pathway and promotes nuclear factor-κB transcription in murine macrophages. | Q39385263 | ||
Regulation of CXCR4 conformation by the small GTPase Rac1: implications for HIV infection | Q39413410 | ||
Poly(ADP-ribose)polymerase-1 is required for integration of the human immunodeficiency virus type 1 genome near centromeric alphoid DNA in human and murine cells | Q40400793 | ||
Poly(ADP-ribose) polymerase-1 is a negative regulator of HIV-1 transcription through competitive binding to TAR RNA with Tat.positive transcription elongation factor b (p-TEFb) complex | Q40501267 | ||
Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase | Q40896649 | ||
Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function. | Q40935198 | ||
Nuclear expression of the 50- and 65-kD Rel-related subunits of nuclear factor-kappa B is differentially regulated in human monocytic cells | Q41020142 | ||
PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis? | Q42107975 | ||
Activation of HIV-1 LTR by Rad51 in microglial cells | Q42182598 | ||
Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery | Q44814390 | ||
Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats | Q48314697 | ||
HIV-1 Tat protein is poly(ADP-ribosyl)ated in vitro | Q77998845 | ||
PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity | Q83461986 | ||
The parp-1 inhibitor ino-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping-induced ischemia/reperfusion | Q83834120 | ||
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 | ||
How HIV takes advantage of the cytoskeleton in entry and replication | Q27021639 | ||
Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions | Q27321704 | ||
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells | Q28270680 | ||
Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase | Q29614246 | ||
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
PARP inhibition: PARP1 and beyond | Q29619617 | ||
HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction | Q30010274 | ||
Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats. | Q33551352 | ||
Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. | Q33648601 | ||
Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor | Q33683180 | ||
HIV-1 neuroimmunity in the era of antiretroviral therapy. | Q33733529 | ||
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals | Q34003966 | ||
Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation | Q34023297 | ||
A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4. | Q34333673 | ||
Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals | Q34544836 | ||
Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration | Q34730830 | ||
The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders | Q35003250 | ||
PARP goes transcription | Q35155777 | ||
Viral exploitation of actin: force-generation and scaffolding functions in viral infection | Q35216851 | ||
NF-κB signaling mediates acquired resistance after PARP inhibition | Q35551882 | ||
Modulation of HIV-1 replication by a novel RhoA effector activity | Q35619856 | ||
Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells | Q35842577 | ||
Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes | Q36062880 | ||
The trinity of the cortical actin in the initiation of HIV-1 infection | Q36156531 | ||
Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. | Q36559702 | ||
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists | Q36775401 | ||
Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. | Q37015360 | ||
P304 | page(s) | 878 | |
P577 | publication date | 2015-08-25 | |
P1433 | published in | Frontiers in Microbiology | Q27723481 |
P1476 | title | The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity | |
P478 | volume | 6 |
Q90512417 | Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide |
Q91639383 | Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4- d ]pyrimidine |
Q27303034 | PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier |
Q59137850 | Structure-based mechanism of action of a viral poly(ADP-ribose) polymerase 1-interacting protein facilitating virus replication |
Q89291574 | The PARP1-Siah1 Axis Controls HIV-1 Transcription and Expression of Siah1 Substrates |
Search more.